Resmed Inc
NYSE:RMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Resmed Inc
NYSE:RMD
|
US |
|
HCA Healthcare Inc
NYSE:HCA
|
US |
|
Barclays PLC
LSE:BARC
|
UK |
|
Yankuang Energy Group Co Ltd
OTC:YZCHF
|
CN |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
M
|
MillerKnoll Inc
SWB:MHR
|
US |
|
A
|
American Express Co
F:AEC1
|
US |
|
M
|
MERLIN Properties SOCIMI SA
ELI:MRL
|
ES |
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
IN |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
Aegon NV
OTC:AEGOF
|
NL |
|
M
|
MPH Health Care AG
XMUN:93M1
|
DE |
|
C
|
Compass Group PLC
OTC:CMPGY
|
UK |
|
J
|
JOYY Inc
XHAM:0YYA
|
SG |
|
E
|
Electronic Arts Inc
F:ERT
|
US |
|
T
|
Taiheiyo Cement Corp
SWB:TIE
|
JP |
|
B
|
Bank of Communications Co Ltd
SWB:C4C
|
CN |
|
Palo Alto Networks Inc
NASDAQ:PANW
|
US |
|
Deutsche Boerse AG
XETRA:DB1
|
DE |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
F
|
First Majestic Silver Corp
XBER:FMV
|
CA |
|
S
|
Sino Land Co Ltd
OTC:SNLAF
|
HK |
Wall St Price Targets
RMD Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RMD is 265.85 USD with a low forecast of 181.8 USD and a high forecast of 341.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMD's stock price target?
Price Target
265.85
USD
According to Wall Street analysts, the average 1-year price target for RMD is 265.85 USD with a low forecast of 181.8 USD and a high forecast of 341.25 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 11%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 10%.
